Lijian Pang
Biographic Data
| ID | 7258234 |
|---|---|
| NAME | Lijian Pang |
| GIVEN NAMES | Lijian |
| FAMILY NAME | Pang |
| SIGNATURE | PANG L |
| AFFILIATIONS | Liaoning University of Traditional Chinese Medicine |
| ORCID | 0000-0002-7300-5019 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2027 |
| H-INDEX | 0 |
Clinical evidence mapping for 54 types of oral Chinese patent medicines used in adult bronchial asthma
ETHNOPHARMACOLOGICAL RELEVANCE: Oral Chinese patent medicines (CPMs), derived from traditional Chinese medicine (TCM), are commonly utilized in China for adult bronchial asthma (BA); however, the scope and quality of clinical evidence supporting their efficacy remain unclear. AIM OF THE REVIEW: To construct an evidence map of clinical research on 54 oral CPMs for adult BA, focusing on their use as add-on therapy with partial monotherapy evidence …
Evidence map analysis of clinical studies on 42 commonly used oral Chinese patent medicines for the treatment of stable chronic obstructive pulmonary disease
This study rigorously and comprehensively evaluated the clinical evidence of Chinese patent medicines (CPMs) in treating the stable phase of chronic obstructive pulmonary disease (COPD), highlighting problems and solutions. This study aimed to systematically evaluate the clinical evidence of 42 oral CPMs for the treatment of stable COPD using evidence mapping, identifying research trends, methodological quality, and gaps in the current literature…
The study for asthma in older adults
Background: Asthma remains a significant public health challenge globally, particularly among older adults who face diagnostic complexity, atypical symptom profiles, and frequent comorbidities. Despite global advances in asthma control, little attention has been paid to the evolving composition and geographic disparity of modifiable risk factors in this age group. Methods: We utilized data from the Global Burden of Disease Study 2021 to evaluate …
The mechanism of Shenlong Jianji treatment of idiopathic pulmonary fibrosis inhibits fibroblast-to-myofibroblast transformation via the TGF-β1/smads signaling pathway
No prominent works on this page.
The mechanism of Shenlong Jianji treatment of idiopathic pulmonary fibrosis inhibits fibroblast-to-myofibroblast transformation via the TGF-β1/smads signaling pathway
The study for asthma in older adults
Background: Asthma remains a significant public health challenge globally, particularly among older adults who face diagnostic complexity, atypical symptom profiles, and frequent comorbidities. Despite global advances in asthma control, little attention has been paid to the evolving composition and geographic disparity of modifiable risk factors in this age group. Methods: We utilized data from the Global Burden of Disease Study 2021 to evaluate …
Evidence map analysis of clinical studies on 42 commonly used oral Chinese patent medicines for the treatment of stable chronic obstructive pulmonary disease
This study rigorously and comprehensively evaluated the clinical evidence of Chinese patent medicines (CPMs) in treating the stable phase of chronic obstructive pulmonary disease (COPD), highlighting problems and solutions. This study aimed to systematically evaluate the clinical evidence of 42 oral CPMs for the treatment of stable COPD using evidence mapping, identifying research trends, methodological quality, and gaps in the current literature…
Clinical evidence mapping for 54 types of oral Chinese patent medicines used in adult bronchial asthma
ETHNOPHARMACOLOGICAL RELEVANCE: Oral Chinese patent medicines (CPMs), derived from traditional Chinese medicine (TCM), are commonly utilized in China for adult bronchial asthma (BA); however, the scope and quality of clinical evidence supporting their efficacy remain unclear. AIM OF THE REVIEW: To construct an evidence map of clinical research on 54 oral CPMs for adult BA, focusing on their use as add-on therapy with partial monotherapy evidence …
Alternative medicine (2 works) · Asthma and respiratory diseases (2 works) · Chinese patent medicine (2 works) · Delphi Technique in Research (2 works) · Internal Medicine (2 works) · Medicine (2 works) · MEDLINE (2 works) · Pathology (2 works) · Respiratory and Cough-Related Research (2 works) · Asthma (1 work)